Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,814 | 874 | 97.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300.24 | 16 | 1.5% |
| Education | $126.67 | 6 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,184 | 104 | $0 (2024) |
| Allergan, Inc. | $1,978 | 104 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $1,629 | 43 | $0 (2024) |
| UCB, Inc. | $1,465 | 66 | $0 (2024) |
| Biogen, Inc. | $1,393 | 76 | $0 (2024) |
| Lundbeck LLC | $874.96 | 39 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $794.86 | 40 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $786.68 | 41 | $0 (2024) |
| Amgen Inc. | $783.70 | 27 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $668.43 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,393 | 117 | ABBVIE INC. ($650.38) |
| 2023 | $2,306 | 93 | ABBVIE INC. ($667.26) |
| 2022 | $3,535 | 139 | Biohaven Pharmaceutical Holding Company Ltd. ($603.17) |
| 2021 | $2,988 | 142 | Biohaven Pharmaceuticals, Inc. ($597.83) |
| 2020 | $1,866 | 104 | Allergan, Inc. ($374.70) |
| 2019 | $1,915 | 85 | Allergan Inc. ($354.21) |
| 2018 | $2,288 | 87 | Allergan Inc. ($483.27) |
| 2017 | $2,950 | 129 | Allergan Inc. ($411.48) |
All Payment Transactions
896 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: PAIN | ||||||
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $26.00 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.62 | General |
| Category: Neuropsychiatry | ||||||
| 11/25/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Immunology | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Central Nervous System | ||||||
| 11/15/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Neurology | ||||||
| 11/13/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: PAIN | ||||||
| 11/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Rare Disease | ||||||
| 11/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: AMANTADINE | ||||||
| 11/01/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Immunology | ||||||
| 10/28/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Neuropsychiatry | ||||||
| 10/22/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Neurology | ||||||
| 10/21/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 704 | 10,330 | $394,024 | $174,724 |
| 2022 | 10 | 581 | 7,550 | $293,950 | $138,238 |
| 2021 | 9 | 623 | 820 | $268,025 | $130,876 |
| 2020 | 9 | 543 | 728 | $232,325 | $96,268 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 17 | 9,393 | $75,080 | $46,671 | 62.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 219 | 363 | $72,600 | $39,245 | 54.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 56 | 57 | $42,750 | $23,803 | 55.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 119 | 119 | $47,600 | $16,873 | 35.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 79 | 166 | $41,452 | $15,157 | 36.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 42 | $10,500 | $6,360 | 60.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 81 | $12,150 | $6,230 | 51.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 35 | 35 | $26,250 | $5,547 | 21.1% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 24 | 25 | $30,566 | $5,347 | 17.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $11,075 | $4,912 | 44.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 24 | 24 | $24,000 | $4,579 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 313 | $61,800 | $34,556 | 55.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 12 | 6,803 | $54,400 | $33,250 | 61.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 51 | 51 | $38,250 | $22,087 | 57.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 101 | 101 | $40,400 | $14,907 | 36.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 54 | 111 | $27,750 | $10,759 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 82 | $12,300 | $6,267 | 50.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 27 | 27 | $20,250 | $4,643 | 22.9% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 20 | 20 | $25,000 | $4,552 | 18.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $7,650 | $3,612 | 47.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 25 | $6,150 | $3,605 | 58.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 216 | 338 | $59,150 | $39,282 | 66.4% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 73 | 75 | $56,250 | $33,745 | 60.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 95 | 95 | $38,000 | $14,907 | 39.2% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 51 | 107 | $26,750 | $10,644 | 39.8% |
About Dr. Steven Ender, DO
Dr. Steven Ender, DO is a Neurology healthcare provider based in Bethpage, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609875657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Ender, DO has received a total of $20,241 in payments from pharmaceutical and medical device companies, with $2,393 received in 2024. These payments were reported across 896 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($19,814).
As a Medicare-enrolled provider, Ender has provided services to 2,451 Medicare beneficiaries, totaling 19,428 services with total Medicare billing of $540,107. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Bethpage, NY
- Active Since 07/20/2005
- Last Updated 10/27/2011
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1609875657
Products in Payments
- BOTOX (Biological) $1,676
- NURTEC ODT (Drug) $1,437
- Briviact (Drug) $836.29
- UBRELVY (Drug) $795.17
- NUPLAZID (Drug) $794.86
- QULIPTA (Drug) $714.53
- VYEPTI (Biological) $631.71
- INGREZZA (Drug) $614.56
- AUSTEDO (Drug) $592.07
- Aimovig (Biological) $580.95
- Vimpat (Drug) $515.01
- TYSABRI (Biological) $497.66
- VUMERITY (Drug) $455.96
- AJOVY (Drug) $420.00
- ULTOMIRIS (Biological) $413.05
- AJOVY (Biological) $405.31
- RYTARY (Drug) $402.43
- BOTOX THERAPEUTIC (Biological) $381.77
- TROKENDI XR (Drug) $342.61
- AIMOVIG (Biological) $338.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bethpage
Vijaya Atluru, M.d, M.D
Neurology — Payments: $11,247
Kenneth Einberg, Md, MD
Neurology — Payments: $8,643
Subbarao Bhimani, M.d, M.D
Neurology — Payments: $1,934
Dr. Gopal Kishore, M.d, M.D
Neurology — Payments: $543.44
Dr. Jane Robin, D.o, D.O
Neurology — Payments: $326.53